Sector valuations Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
Equities
600329
CNE000001808
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.70 CNY | -1.09% |
|
-1.02% | -10.78% |
| Mar. 31 | Tianjin Pharmaceutical Da Ren Tang's Attributable Profit Drops 4.4% in 2025 | MT |
| Mar. 31 | Singapore Shares Remain in Red Amid Soaring Energy Costs; Rex International Plunges 20% | MT |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 27.88x | - | -0.59x | - | - | - | - | 4.06B | |
| 17.45x | 2.38x | 1.81x | 2.12x | 13.81x | 14.52x | 5.08% | 14.47B | |
| 28.41x | 2.54x | 2.26x | 1.57x | 10.45x | 11.91x | 1.45% | 5.58B | |
| 17.52x | 3.13x | 1.23x | 3.57x | 11.36x | 11.51x | 5.7% | 5.09B | |
| 23.18x | 2.42x | -0.09x | - | - | - | 1.56% | 4.09B | |
| 15.79x | 1.6x | 0.72x | 2.12x | 9.46x | 12.33x | 2.84% | 3.12B | |
| 15.18x | 3.69x | 1.81x | 2.74x | 11.7x | 12.69x | 5.2% | 1.74B | |
| 41.57x | - | -0.1x | - | - | - | - | 1.03B | |
| 12.15x | 4.51x | 4.96x | 3.37x | 8.48x | 9.12x | 7.6% | 882M | |
| Average | 22.13x | 2.90x | 1.34x | 2.58x | 10.87x | 12.01x | 4.21% | 4.45B | |
| Weighted average by Cap. | 20.90x | 2.57x | 1.30x | 2.33x | 12.09x | 13.07x | 4.05% |
Select your edition
All financial news and data tailored to specific country editions
